Charlesson's News
10/15/2007:
Ocular Pharmaceutical Company Charlesson Announces $2.35MM in New Funding
09/26/2007:
Charlesson receives $1,141,000 grant from the National Institutes of Health to develop nanotechnology-based treatments for Diabetic Retinopathy
09/17/2007:
Charlesson scientist, Dr. Danyang Chen, receives $840,000 Phase II SBIR grant from the National Institutes of Health to develop CLT-003 for the treatment of Diabetic Macular Edema
09/05/2007:
Charlesson selected as a Finalist for the 2007 Grace & Franklin Bernsen most promising new business award
08/13/2007:
Charlesson scientist, Dr. Rafal Farjo, featured as an expert guest on Oklahoma Innovations Radio Show.
05/22/2007:
Charlesson scientist, Dr. Rafal Farjo, receives $135,000 grant from the Oklahoma Center for Advancement of Science and Technology to develop gene therapy treatments for blinding diseases